CVS Health - CVS Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Moderate Buy
Consensus Price Target: $89.44
Forecasted Upside: 28.90%
Number of Analysts: 15
Breakdown:
0 Sell Ratings
3 Hold Ratings
12 Buy Ratings
0 Strong Buy Ratings

^$69.39 As of 04/18/2024 01:00 AM ET

▲ +0.79 (1.15%)

1 month | 3 months | 12 months

Get New CVS Health Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for CVS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CVS

^$89.44

▲ +28.90% Upside Potential

This price target is based on 15 analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is $89.44, with a high forecast of $106.00 and a low forecast of $76.00. The average price target represents a 28.90% upside from the last price of $69.39.

Current Consensus is Moderate Buy

The current consensus among 15 polled investment analysts is to moderate buy stock in CVS Health. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

10/26/2022

0 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

1/24/2023

0 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

4/24/2023

0 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

7/23/2023

0 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

10/21/2023

0 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

1/19/2024

0 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

3/19/2024

0 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

4/18/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/10/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$87.00	Low
4/8/2024	Wells Fargo & Company	Lower Target	Equal Weight ➝ Equal Weight	$83.00 ➝ $76.00	Low
4/4/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$87.00	Low
3/15/2024	Piper Sandler	Boost Target	Overweight ➝ Overweight	$93.00 ➝ $94.00	Low
3/6/2024	Barclays	Initiated Coverage	Equal Weight	$78.00	Low
2/26/2024	Leerink Partnrs	Reiterated Rating	Outperform		Low
2/26/2024	SVB Leerink	Initiated Coverage	Outperform	$88.00	Low
2/8/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$87.00	Low
2/8/2024	Royal Bank of Canada	Lower Target	Outperform ➝ Outperform	$86.00 ➝ $84.00	Low
12/22/2023	HSBC	Initiated Coverage	Buy	$94.00	Low
12/11/2023	TD Cowen	Lower Target	Outperform ➝ Outperform	$102.00 ➝ $99.00	Low
11/21/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$87.00	Low
11/2/2023	Morgan Stanley	Lower Target	Overweight ➝ Overweight	$110.00 ➝ $100.00	N/A
11/2/2023	Royal Bank of Canada	Lower Target	Outperform ➝ Outperform	$91.00 ➝ $86.00	N/A
10/10/2023	Sanford C. Bernstein	Lower Target		$93.00 ➝ $80.00	Low
9/19/2023	Evercore ISI	Upgrade	In-Line ➝ Outperform	$81.00 ➝ $83.00	Low
9/14/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$87.00	Low
9/12/2023	Wolfe Research	Upgrade	Peer Perform ➝ Outperform	$80.00	Low
9/1/2023	Piper Sandler	Lower Target	Overweight ➝ Overweight	$85.00 ➝ $82.00	Low
8/18/2023	Royal Bank of Canada	Reiterated Rating	Outperform ➝ Outperform	$91.00	Low
8/17/2023	Edward Jones	Downgrade	Buy ➝ Hold		Low
8/4/2023	Raymond James	Lower Target	Outperform ➝ Outperform	$90.00 ➝ $85.00	Low
8/3/2023	Morgan Stanley	Lower Target	Overweight ➝ Overweight	$120.00 ➝ $110.00	Low
8/3/2023	Royal Bank of Canada	Lower Target	Outperform ➝ Outperform	$102.00 ➝ $91.00	Low
8/3/2023	Truist Financial	Lower Target	Buy ➝ Buy	$103.00 ➝ $98.00	Low
8/3/2023	Barclays	Lower Target	Overweight ➝ Overweight	$89.00 ➝ $86.00	Low
7/12/2023	Barclays	Lower Target		$90.00 ➝ $89.00	Low
7/11/2023	Mizuho	Lower Target		$120.00 ➝ $88.00	Low
7/7/2023	JPMorgan Chase & Co.	Lower Target		$114.00 ➝ $106.00	Low
6/20/2023	Truist Financial	Lower Target		$109.00 ➝ $103.00	Low
5/30/2023	JPMorgan Chase & Co.	Lower Target		$125.00 ➝ $114.00	Low
5/25/2023	Piper Sandler	Initiated Coverage	Overweight	$85.00	Low
5/8/2023	Wells Fargo & Company	Lower Target		$95.00 ➝ $76.00	Low
5/8/2023	Credit Suisse Group	Lower Target		$125.00 ➝ $96.00	Low
5/4/2023	Truist Financial	Lower Target		$115.00 ➝ $109.00	Low
5/4/2023	Barclays	Lower Target		$100.00 ➝ $90.00	Low
5/2/2023	UBS Group	Lower Target		$102.00 ➝ $94.00	Low
5/2/2023	Sanford C. Bernstein	Lower Target		$107.00 ➝ $93.00	Low
4/20/2023	Cantor Fitzgerald	Initiated Coverage	Overweight	$87.00	Low
4/10/2023	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold		Low
3/31/2023	Bank of America	Lower Target	Buy	$111.00 ➝ $104.00	Low
3/30/2023	Barclays	Lower Target	Overweight	$110.00 ➝ $100.00	Low
2/9/2023	Royal Bank of Canada	Reiterated Rating	Outperform	$115.00	Low
2/9/2023	Jefferies Financial Group	Boost Target	Buy	$130.00 ➝ $143.00	Low
2/9/2023	Raymond James	Lower Target	Outperform	$115.00 ➝ $110.00	Low
2/9/2023	Barclays	Lower Target	Overweight	$118.00 ➝ $110.00	Low
1/13/2023	Morgan Stanley	Boost Target	Overweight	$119.00 ➝ $120.00	Low
1/3/2023	Wells Fargo & Company	Lower Target	Equal Weight	$106.00 ➝ $101.00	Low
11/23/2022	Morgan Stanley	Lower Target	Overweight	$124.00 ➝ $119.00	Low
11/21/2022	Credit Suisse Group	Boost Target	Outperform	$117.00 ➝ $125.00	Low
11/8/2022	Wells Fargo & Company	Lower Target	Equal Weight	$111.00 ➝ $106.00	Low
11/7/2022	Royal Bank of Canada	Lower Target	Outperform	$119.00 ➝ $115.00	Low
11/6/2022	Raymond James	Lower Target		$120.00 ➝ $115.00	Low
11/3/2022	JPMorgan Chase & Co.	Lower Target	Overweight	$130.00 ➝ $125.00	Low
11/3/2022	The Goldman Sachs Group	Lower Target	Buy	$128.00 ➝ $113.00	Low
10/20/2022	Bank of America	Lower Target	Buy	$122.00 ➝ $118.00	Low
10/11/2022	Morgan Stanley	Lower Target	Overweight	$127.00 ➝ $124.00	Low
9/7/2022	Evercore ISI	Boost Target	Outperform	$120.00 ➝ $125.00	Low
8/17/2022	Tigress Financial	Boost Target		$125.00 ➝ $130.00	Low
8/15/2022	Mizuho	Boost Target	Buy	$115.00 ➝ $120.00	Low
8/8/2022	Credit Suisse Group	Boost Target	Outperform	$113.00 ➝ $117.00	Low
8/4/2022	UBS Group	Boost Target	Buy	$118.00 ➝ $127.00	Low
8/4/2022	Deutsche Bank Aktiengesellschaft	Boost Target		$113.00 ➝ $120.00	Low
6/16/2022	Loop Capital	Initiated Coverage	Buy	$120.00	Medium
5/26/2022	Sanford C. Bernstein	Downgrade	Outperform ➝ Market Perform	$122.00 ➝ $112.00	Medium
5/5/2022	Deutsche Bank Aktiengesellschaft	Boost Target		$110.00 ➝ $113.00	High
4/7/2022	Tigress Financial	Boost Target		$122.00 ➝ $125.00	Low
3/29/2022	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$110.00	High
2/17/2022	Deutsche Bank Aktiengesellschaft	Boost Target		$107.00 ➝ $110.00	Medium
2/11/2022	Raymond James	Downgrade	Strong-Buy ➝ Outperform	$115.00 ➝ $120.00	High
2/10/2022	BMO Capital Markets	Boost Target		$108.00 ➝ $120.00	Medium
1/12/2022	Robert W. Baird	Boost Target		$107.00 ➝ $110.00	Low
1/11/2022	Sanford C. Bernstein	Boost Target		$111.00 ➝ $116.00	Low
1/10/2022	Edward Jones	Upgrade	Hold ➝ Buy		Medium
1/5/2022	Truist Financial	Boost Target	Buy ➝ Buy	$118.00 ➝ $124.00	Low
12/23/2021	Tigress Financial	Boost Target	Buy	$108.00 ➝ $122.00	Low
12/20/2021	Mizuho	Boost Target	Buy	$110.00 ➝ $115.00	Low
12/14/2021	Robert W. Baird	Reiterated Rating	Hold		Low
12/14/2021	The Goldman Sachs Group	Initiated Coverage	Buy	$121.00	Low
12/13/2021	Morgan Stanley	Boost Target	Overweight ➝ Overweight	$115.00 ➝ $125.00	Low
12/13/2021	Wells Fargo & Company	Boost Target	Equal Weight ➝ Equal Weight	$98.00 ➝ $107.00	Low
12/13/2021	Robert W. Baird	Boost Target	Neutral ➝ Neutral	$100.00 ➝ $107.00	Low
12/10/2021	Truist Financial	Boost Target	Buy ➝ Buy	$112.00 ➝ $118.00	Low
12/10/2021	Cowen	Boost Target	Outperform ➝ Outperform	$103.00 ➝ $114.00	Low
12/10/2021	Royal Bank of Canada	Boost Target	Outperform ➝ Outperform	$107.00 ➝ $119.00	Medium
12/10/2021	Credit Suisse Group	Boost Target	Outperform ➝ Outperform	$107.00 ➝ $120.00	Medium
12/10/2021	Mizuho	Boost Target	Buy ➝ Buy	$105.00 ➝ $110.00	Medium
12/6/2021	Morgan Stanley	Boost Target	Overweight	$114.00 ➝ $115.00	Medium
12/1/2021	Seaport Res Ptn	Reiterated Rating	Buy		Medium
11/10/2021	Mizuho	Boost Target	Buy	$98.00 ➝ $105.00	Low
11/5/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$101.00 ➝ $107.00	Medium
11/5/2021	Credit Suisse Group	Boost Target	Outperform	$100.00 ➝ $107.00	Low
11/5/2021	JPMorgan Chase & Co.	Boost Target	Buy ➝ Overweight	$107.00 ➝ $115.00	Low
11/4/2021	Truist Financial	Boost Target	Buy	$94.00 ➝ $112.00	Medium
11/4/2021	Royal Bank of Canada	Boost Target	Outperform	$97.00 ➝ $107.00	Medium
11/4/2021	Raymond James	Boost Target	Strong-Buy	$95.00 ➝ $115.00	Medium
11/4/2021	Citigroup	Boost Target	Buy	$98.00 ➝ $111.00	Medium
11/4/2021	Barclays	Boost Target	Overweight	$100.00 ➝ $110.00	Medium
10/21/2021	Mizuho	Reiterated Rating	Buy		Medium
8/31/2021	Morgan Stanley	Boost Target	Top Pick ➝ Overweight	$99.00 ➝ $114.00	High
8/5/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$95.00 ➝ $101.00	High
7/23/2021	Tigress Financial	Reiterated Rating	Buy	$108.00	Low
6/22/2021	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$99.00 ➝ $95.00	Low
5/24/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$89.00	N/A
5/19/2021	BMO Capital Markets	Boost Target	Positive ➝ Market Perform	$90.00 ➝ $96.00	High
5/19/2021	Barclays	Boost Target	Overweight	$92.00 ➝ $100.00	High
5/19/2021	Wolfe Research	Boost Target	Positive ➝ Outperform	$82.00 ➝ $93.00	High
5/18/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$89.00	Medium
5/12/2021	Mizuho	Boost Target	Positive ➝ Buy	$82.00 ➝ $98.00	Low
5/6/2021	Credit Suisse Group	Boost Target	Outperform	$91.00 ➝ $100.00	Low
5/6/2021	BMO Capital Markets	Boost Target	Market Perform	$82.00 ➝ $90.00	Low
5/5/2021	Citigroup	Boost Target		$83.00 ➝ $98.00	Medium
5/5/2021	Jefferies Financial Group	Boost Target	Buy	$90.00 ➝ $95.00	Medium
5/5/2021	Raymond James	Boost Target	Strong-Buy	$90.00 ➝ $95.00	High
5/5/2021	Royal Bank of Canada	Boost Target	Outperform	$80.00 ➝ $91.00	High
4/14/2021	Truist Financial	Boost Target	Buy	$80.00 ➝ $88.00	Low
4/14/2021	Morgan Stanley	Boost Target	Overweight	$86.00 ➝ $92.00	Medium
3/23/2021	Guggenheim	Reiterated Rating	Buy ➝ Neutral		Medium
3/17/2021	Guggenheim	Downgrade	Buy ➝ Neutral		Low
1/8/2021	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$90.00	Low
12/14/2020	SVB Leerink	Boost Target	Market Perform	$73.00 ➝ $80.00	High
11/11/2020	Piper Sandler	Boost Target	Overweight	$72.00 ➝ $76.00	Low
11/9/2020	Cantor Fitzgerald	Reiterated Rating	Overweight		High
11/9/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$104.00 ➝ $101.00	High
9/17/2020	Piper Sandler	Initiated Coverage	Overweight	$72.00 ➝ $72.00	Medium
8/7/2020	Credit Suisse Group	Boost Target	Outperform	$75.00 ➝ $90.00	Medium
8/6/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$109.00 ➝ $104.00	Low
8/6/2020	SVB Leerink	Boost Target	Market Perform	$72.00 ➝ $73.00	Low
7/9/2020	Royal Bank of Canada	Reiterated Rating	Buy		Low
7/1/2020	SVB Leerink	Initiated Coverage	Market Perform	$72.00	Low
5/14/2020	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$75.00	Low
5/8/2020	Credit Suisse Group	Reiterated Rating	Hold		Low
5/7/2020	Robert W. Baird	Boost Target	Neutral	$62.00 ➝ $66.00	Low
5/7/2020	UBS Group	Lower Target	Buy	$85.00 ➝ $79.00	Low
5/7/2020	Citigroup	Lower Target	Buy	$86.00 ➝ $75.00	Low
5/7/2020	Morgan Stanley	Boost Target	Overweight	$71.00 ➝ $77.00	Low
5/6/2020	Royal Bank of Canada	Reiterated Rating	Buy	$77.00	High
5/6/2020	Oppenheimer	Reiterated Rating	Hold		High
5/4/2020	JPMorgan Chase & Co.	Lower Target	Overweight	$97.00 ➝ $94.00	Low
4/24/2020	Tigress Financial	Reiterated Rating	Buy		Medium
4/13/2020	Morgan Stanley	Boost Target	Overweight	$70.00 ➝ $71.00	Low
4/13/2020	SunTrust Banks	Lower Target	Buy	$90.00 ➝ $80.00	Medium
4/12/2020	Royal Bank of Canada	Reiterated Rating	Buy	$77.00	High
3/27/2020	Morgan Stanley	Lower Target	Overweight	$88.00 ➝ $70.00	Medium
3/27/2020	Robert W. Baird	Lower Target	Neutral	$73.00 ➝ $62.00	Medium
3/25/2020	Royal Bank of Canada	Lower Target		$85.00 ➝ $81.00	Medium
3/19/2020	Credit Suisse Group	Reiterated Rating	Hold	$75.00	Medium
2/18/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$97.00 ➝ $109.00	Low
2/14/2020	Citigroup	Boost Target	Buy	$83.00 ➝ $86.00	Medium
2/13/2020	Robert W. Baird	Boost Target	Neutral	$70.00 ➝ $73.00	Medium
2/13/2020	UBS Group	Boost Target	Buy	$78.00 ➝ $85.00	Medium
2/13/2020	Cantor Fitzgerald	Boost Target	Overweight	$85.00 ➝ $90.00	Medium
2/12/2020	Oppenheimer	Initiated Coverage	Hold		Medium
2/12/2020	Cfra	Boost Target	Strong-Buy	$85.00 ➝ $86.00	Medium
12/19/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$88.00 ➝ $97.00	Low
12/4/2019	Raymond James	Reiterated Rating	Strong-Buy	$80.00 ➝ $90.00	Low
11/8/2019	Mizuho	Boost Target	Buy	$71.00 ➝ $82.00	Low
11/7/2019	UBS Group	Reiterated Rating	Buy	$78.00 ➝ $78.00	Low
11/7/2019	Raymond James	Boost Target	Strong-Buy	$75.00 ➝ $80.00	Low
11/7/2019	SunTrust Banks	Boost Target	Buy	$85.00	Low
11/7/2019	Citigroup	Boost Target	Buy	$72.00 ➝ $83.00	Low
10/21/2019	Cowen	Set Target	Buy	$76.00	Low
9/27/2019	Royal Bank of Canada	Initiated Coverage	Outperform	$85.00	Low
9/26/2019	Morgan Stanley	Boost Target	Overweight	$74.00 ➝ $77.00	Medium
9/12/2019	Bank of America	Boost Target	Buy	$72.00 ➝ $75.00	Low
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$91.00	Medium
8/27/2019	Cowen	Reiterated Rating	Outperform	$69.00 ➝ $76.00	Medium
8/11/2019	Morgan Stanley	Reiterated Rating	Buy	$74.00	Low
8/8/2019	Citigroup	Boost Target	Buy	$68.00 ➝ $72.00	Medium
8/7/2019	Evercore ISI	Set Target	Buy	$63.00	Low
6/5/2019	Mizuho	Set Target	Buy	$71.00	Medium
6/5/2019	Standpoint Research	Upgrade	Hold ➝ Buy		High
5/3/2019	BMO Capital Markets	Set Target	Hold	$63.00	Low
5/2/2019	Citigroup	Set Target	Buy	$74.00	Low
5/2/2019	UBS Group	Lower Target	Sell ➝ Sell	$74.00 ➝ $67.00	Low
5/1/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$80.00	Low
4/29/2019	Morgan Stanley	Lower Target	Overweight ➝ Overweight	$92.00 ➝ $74.00	Low
4/29/2019	Credit Suisse Group	Downgrade	Outperform ➝ Neutral	$73.00 ➝ $61.00	Medium
4/21/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$80.00	Low

(Data available from 4/19/2019 forward)

News Sentiment Rating

0.74 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

28 very positive mentions
58 positive mentions
14 negative mentions
7 very negative mentions

Mentions as of

9/22/2023

48 very positive mentions
38 positive mentions
16 negative mentions
2 very negative mentions

Mentions as of

10/22/2023

17 very positive mentions
48 positive mentions
16 negative mentions
6 very negative mentions

Mentions as of

11/21/2023

47 very positive mentions
43 positive mentions
4 negative mentions
4 very negative mentions

Mentions as of

12/21/2023

44 very positive mentions
52 positive mentions
1 negative mentions
2 very negative mentions

Mentions as of

1/20/2024

49 very positive mentions
44 positive mentions
10 negative mentions
3 very negative mentions

Mentions as of

2/19/2024

39 very positive mentions
72 positive mentions
7 negative mentions
5 very negative mentions

Mentions as of

3/20/2024

41 very positive mentions
38 positive mentions
7 negative mentions
1 very negative mentions

Mentions as of

4/19/2024

Current Sentiment

Recent Stories by Sentiment

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Today's Range

Now: $69.39

$68.86

$69.60

50 Day Range

MA: $75.42

$68.58

$79.76

52 Week Range

Now: $69.39

$64.41

$83.25

Volume

10,064,442 shs

Average Volume

10,895,185 shs

Market Capitalization

$87.46 billion

P/E Ratio

10.74

Dividend Yield

3.85%

Beta

0.52

Frequently Asked Questions

What sell-side analysts currently cover shares of CVS Health?: The following Wall Street analysts have issued stock ratings on CVS Health in the last twelve months: Barclays PLC, Cantor Fitzgerald, Credit Suisse Group AG, Edward Jones, Evercore ISI, HSBC Holdings plc, JPMorgan Chase & Co., Leerink Partnrs, Mizuho, Morgan Stanley, Piper Sandler, Raymond James, Royal Bank of Canada, Sanford C. Bernstein, StockNews.com, SVB Leerink LLC, TD Cowen, TheStreet, Truist Financial Co., UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for CVS.
What is the current price target for CVS Health?: 18 Wall Street analysts have set twelve-month price targets for CVS Health in the last year. Their average twelve-month price target is $89.44, suggesting a possible upside of 28.9%. JPMorgan Chase & Co. has the highest price target set, predicting CVS will reach $106.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $76.00 for CVS Health in the next year.
View the latest price targets for CVS.
What is the current consensus analyst rating for CVS Health?: CVS Health currently has 3 hold ratings and 12 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CVS.
What other companies compete with CVS Health?: Other companies that are similar to CVS Health include Chipotle Mexican Grill, Starbucks, Target, MercadoLibre and TJX Companies. Learn More about companies similar to CVS Health.
How do I contact CVS Health's investor relations team?: CVS Health's physical mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator's listed phone number is (401) 765-1500 and its investor relations email address is [email protected]. The official website for CVS Health is www.cvshealth.com. Learn More about contacing CVS Health investor relations.

CVS Health - CVS Stock Price Target and Predictions

Analyst Price Target for CVS

Current Consensus is Moderate Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.74 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of CVS Health?

What is the current price target for CVS Health?

What is the current consensus analyst rating for CVS Health?

What other companies compete with CVS Health?

How do I contact CVS Health's investor relations team?